DudeDiligence.

Syndax Pharmaceuticals, Inc

SNDXNASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Revenue
$289.7Mlast 12 months
Net income
−$209.5Mlast 12 months
Operating cash flow
−$220.6Mlast 12 months
Cash and equivalents
$135.9Mat the last balance sheet
Total debt
$344.1Mat the last balance sheet
Shares outstanding
90.0M shareson issue
Every year and quarter →